FOGHORN THERAPEUTICS INC (FHTX) — insider trading
Health Care · NASDAQ
FOGHORN THERAPEUTICS INC (FHTX) has 14 reported SEC Form 4 insider transactions in our data (latest 2026-06-24).
Recent Form 4 transactions
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-06-24 | Cole Douglas G. | Director | Grant / award / vesting (derivative) | 28,000 | $4.08 | $114.2K | Form 4 |
| 2026-06-24 | PARSHALL B LYNNE | Director | Grant / award / vesting (derivative) | 28,000 | $4.08 | $114.2K | Form 4 |
| 2026-06-24 | GILL SIMBA | Director | Grant / award / vesting (derivative) | 28,000 | $4.08 | $114.2K | Form 4 |
| 2026-06-24 | SMITH IAN F | Director | Grant / award / vesting (derivative) | 28,000 | $4.08 | $114.2K | Form 4 |
| 2026-06-24 | Mendelsohn Michael | Director | Grant / award / vesting (derivative) | 28,000 | $4.08 | $114.2K | Form 4 |
| 2026-06-24 | Gallagher Neil | Director | Grant / award / vesting (derivative) | 28,000 | $4.08 | $114.2K | Form 4 |
| 2026-06-24 | Biller Scott | Director | Grant / award / vesting (derivative) | 28,000 | $4.08 | $114.2K | Form 4 |
| 2026-06-24 | Duty Stuart | Director | Grant / award / vesting (derivative) | 28,000 | $4.08 | $114.2K | Form 4 |
| 2026-06-24 | Lynch Thomas J. Jr. | Director | Grant / award / vesting (derivative) | 28,000 | $4.08 | $114.2K | Form 4 |
| 2026-04-10 | GOTTSCHALK ADRIAN | Director, Officer (Chief Executive Officer) | Bona fide gift | 59,208 | $0.00 | $0 | Form 4 |
| 2026-04-10 | GOTTSCHALK ADRIAN | Director, Officer (Chief Executive Officer) | Bona fide gift | 59,208 | $0.00 | $0 | Form 4 |
| 2026-04-09 | GOTTSCHALK ADRIAN | Director, Officer (Chief Executive Officer) | Bona fide gift | 47,497 | $0.00 | $0 | Form 4 |
| 2026-04-09 | GOTTSCHALK ADRIAN | Director, Officer (Chief Executive Officer) | Bona fide gift | 47,497 | $0.00 | $0 | Form 4 |
| 2026-02-23 | Maynard Ryan D | Officer (Chief Financial Officer) | Grant / award / vesting (derivative) | 400,000 | $5.75 | $2.30M | Form 4 |
Ask the chat about FHTX's insider activity →
Transaction types are the SEC Form 4 codes: open-market purchases (P) and sales (S) are the only rows that reflect open-market conviction. Awards/vesting (A), option exercises (M/X/C), shares withheld for taxes (F) and gifts (G) are compensation or mechanical, not buying or selling on the open market. Sales may be planned and non-discretionary (e.g. a Rule 10b5-1 plan); open-market buying is not a recommendation to buy. Informational only — not financial advice.
Source: SEC EDGAR Form 3/4/5. See the full company profile: FOGHORN THERAPEUTICS INC (FHTX).
Last updated 2026-06-24 (most recent filing date).
Informational only — NOT financial advice. Insider filings are sourced from SEC EDGAR and shown with their reported dates.